Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
20 participants
INTERVENTIONAL
2007-12-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebrospinal Fluid (CSF) Drainage Study
NCT01420978
Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage
NCT01400360
Effects of Cerebrospinal Fluid Drainage on Cerebral Hemodynamics
NCT07056907
EARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAH
NCT01258257
Brain Aneurysms: Utility of Cisternal Urokinase Irrigation
NCT04792944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We aim to assess whether external lumbar drainage (ELD) of CSF is safe and reduces secondary ischemia and its sequelae.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
external lumbar drainage
Within 96 hours of initial subarachnoid hemorrhage, patients were randomized for external lumbar drainage (ELD)of cerebrospinal fluid during a maximum of 7 days or standard treatment of subarachnoid hemorrhage without ELD
external lumbar drainage (ELD) of cerebrospinal fluid
Patients were randomized for external lumbar drainage of cerebrospinal fluid or standard treatment of a subarachnoid hemorrhage alone. External drainage was started within 96 hours of initial subarachnoid hemorrhage during 7 days at a maximum of 5-10 ml/hour.
No intervention
In this arm the patients received standard treatment following protocol for patients with subarachnoid hemorrhage
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
external lumbar drainage (ELD) of cerebrospinal fluid
Patients were randomized for external lumbar drainage of cerebrospinal fluid or standard treatment of a subarachnoid hemorrhage alone. External drainage was started within 96 hours of initial subarachnoid hemorrhage during 7 days at a maximum of 5-10 ml/hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CSF drainage by external lumbar catheter can start within 96 hours after the initial SAH
* the drainage can start prior to the treatment of the ruptured aneurysm
* informed consent is signed by the patient or his representative
Exclusion Criteria
* traumatic SAH
* symptomatic hydrocephalus on admission necessitating drainage (EVD or ELD)
* the presence of a large intraventricular bloodclot in the third or fourth ventricle on CT
* the presence of a mass lesion with significant cerebral midline shift
* all patients whose neurological condition is too poor to allow clinical recognition of signs and symptoms of cerebral vasospasm. This includes all patients with a Hunt and Hess Grade V who failed to improve after initial resuscitation
* no informed consent
* mycotic aneurysms
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elisabeth-TweeSteden Ziekenhuis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neurosurgery St Elisabeth Hospital The Netherlands
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Depauw, MD
Role: PRINCIPAL_INVESTIGATOR
Elisabeth-TweeSteden Ziekenhuis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Elisabeth Hospital
Tilburg, North Brabant, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15378
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.